Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

H.H. Hartgrink; Cornelis J.�H. van de Velde; Hein Putter; Ilfet Songun; Margot Tesselaar; Elma Meershoek‐Klein Kranenbarg; J.E. de Vries; J. Wils; Jaap van der Bijl; J. Han van Krieken

doi:10.1016/j.ejso.2004.04.013

Keywords

MedicineChemotherapySurgeryRegimenRandomized controlled trialCancerStage (stratigraphy)MethotrexateStomach cancerInternal medicine

Affiliated Institutions

Related Publications

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters , A. Norman , David Cunningham +12 more

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF re...

1999 British Journal of Cancer 278 citations

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

David Cunningham , William Allum , Sally Stenning +12 more

In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free ...

2006 New England Journal of Medicine 6200 citations

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb , David Cunningham , J.H. Scarffe +16 more

PURPOSE We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil (5-FU) (ECF...

1997 Journal of Clinical Oncology 871 citations

Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)

David Cunningham , W H Allum , SP Stenning +1 more

4001 Background: Epirubicin, Cisplatin and infused 5-FU (ECF) shows significant benefit in advanced oesophagogastric cancer, particularly locally advanced disease. This trial wa...

2005 Journal of Clinical Oncology 117 citations

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

J. Hermans , Johannes J. Bonenkamp , M. C. Boon +4 more

PURPOSE An overview is presented of reports published since 1980, in which postoperative adjuvant chemotherapy is compared with surgery alone for patients with gastric cancer. A...

1993 Journal of Clinical Oncology 551 citations

Publication Info

Year: 2004
Type: article
Volume: 30
Issue: 6
Pages: 643-649
Citations: 198
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

198

OpenAlex

Cite This

APA Style

                            
                                
                                    H.H. Hartgrink, 
                                
                                    Cornelis J.�H. van de Velde, 
                                
                                    Hein Putter
                                
                                et al.
                            
                            (2004). 
                            Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. 
                            European Journal of Surgical Oncology
                            , 30
                            (6)
                            , 643-649.
                            https://doi.org/10.1016/j.ejso.2004.04.013
                        

Identifiers

DOI: 10.1016/j.ejso.2004.04.013